Department of Immunotechnology
31 – 40 of 116
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Analysis of the Molecular Crosstalk Between Tumor Cells and the Microenvironment in Lymphatic Metastasis
- Master (Two yrs)
-
Mark
Towards Establishment of an Ex Vivo Bladder Tumor Model using Precision Cut Tumor Slices (PCTS) for Evaluation of Existing and Novel Treatments
- Master (Two yrs)
-
Mark
Prognostic impact of CD163 and CD11c in B cell lymphomas
- Master (Two yrs)
-
Mark
Establishment and Characterization of Innovative Immunoreagents for Diagnosis of Neurodegenerative Disease
- Master (Two yrs)
- 2023
-
Mark
Investigations of immune population subsets in bladder cancer
- Master (Two yrs)
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
- Master (Two yrs)
-
Mark
Dendritic cell stress responses after exposure to a novel rubber skin sensitizer
- Master (Two yrs)
-
Mark
Estimation of immune infiltration in tumours using proteomics data
- Master (Two yrs)
-
Mark
The Effects of Chemotherapy on B Cells and T Cells in Blood and Tumor Tissue in Patients with Pancreatic Cancer – from Diagnosis to Terminal Disease
- Master (Two yrs)